Human papillomavirus type 16 E7 oncoprotein associates with the cullin 2 ubiquitin ligase complex, which contributes to degradation of the retinoblastoma tumor suppressor
- PMID: 17609271
- PMCID: PMC2045412
- DOI: 10.1128/JVI.00881-07
Human papillomavirus type 16 E7 oncoprotein associates with the cullin 2 ubiquitin ligase complex, which contributes to degradation of the retinoblastoma tumor suppressor
Abstract
Human papillomavirus type 16 (HPV16) and other high-risk HPVs are etiologically linked to the development of cervical carcinomas and contribute to a number of other tumors of the anogenital tract, as well as oral cancers. The high-risk HPV E6 and E7 oncoproteins are consistently expressed in cervical cancer cells and are necessary for the induction and maintenance of the transformed phenotype. An important aspect of HPV16 E7's oncogenic activities is destabilization of the retinoblastoma tumor suppressor (pRB) through a ubiquitin/proteasome-dependent mechanism, although the exact molecular mechanism is unknown. Here, we report that HPV16 E7 is associated with an enzymatically active cullin 2 ubiquitin ligase complex and that the HPV16 E7/pRB complex contains cullin 2. Depletion of cullin 2 by RNA interference causes increased steady-state levels and stability of pRB in HPV16 E7-expressing cells, and ectopic expression of HPV16 E7 and the cullin 2 complex leads to pRB ubiquitination in vivo. Hence, we propose that the HPV16 E7-associated cullin 2 ubiquitin ligase complex contributes to aberrant degradation of the pRB tumor suppressor in HPV16 E7-expressing cells.
Figures
Similar articles
-
The membrane-associated ubiquitin ligase MARCHF8 stabilizes the human papillomavirus oncoprotein E7 by degrading CUL1 and UBE2L3 in head and neck cancer.J Virol. 2024 Feb 20;98(2):e0172623. doi: 10.1128/jvi.01726-23. Epub 2024 Jan 16. J Virol. 2024. PMID: 38226814 Free PMC article.
-
Both Rb and E7 are regulated by the ubiquitin proteasome pathway in HPV-containing cervical tumor cells.Oncogene. 2001 Aug 2;20(34):4740-9. doi: 10.1038/sj.onc.1204655. Oncogene. 2001. PMID: 11498796
-
Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).J Virol. 2015 May;89(10):5276-87. doi: 10.1128/JVI.03434-14. Epub 2015 Feb 25. J Virol. 2015. PMID: 25717103 Free PMC article.
-
Cellular targets of the oncoproteins encoded by the cancer associated human papillomaviruses.Princess Takamatsu Symp. 1991;22:239-48. Princess Takamatsu Symp. 1991. PMID: 1668886 Review.
-
Interactions of HPV E6 and E7 oncoproteins with tumour suppressor gene products.Cancer Surv. 1992;12:197-217. Cancer Surv. 1992. PMID: 1322242 Review.
Cited by
-
Structural analysis of PTPN21 reveals a dominant-negative effect of the FERM domain on its phosphatase activity.Sci Adv. 2024 Mar;10(9):eadi7404. doi: 10.1126/sciadv.adi7404. Epub 2024 Feb 28. Sci Adv. 2024. PMID: 38416831 Free PMC article.
-
The Hallmarks of Cervical Cancer: Molecular Mechanisms Induced by Human Papillomavirus.Biology (Basel). 2024 Jan 27;13(2):77. doi: 10.3390/biology13020077. Biology (Basel). 2024. PMID: 38392296 Free PMC article. Review.
-
The membrane-associated ubiquitin ligase MARCHF8 stabilizes the human papillomavirus oncoprotein E7 by degrading CUL1 and UBE2L3 in head and neck cancer.J Virol. 2024 Feb 20;98(2):e0172623. doi: 10.1128/jvi.01726-23. Epub 2024 Jan 16. J Virol. 2024. PMID: 38226814 Free PMC article.
-
Epidemiology, Molecular Pathogenesis, Immuno-Pathogenesis, Immune Escape Mechanisms and Vaccine Evaluation for HPV-Associated Carcinogenesis.Pathogens. 2023 Nov 23;12(12):1380. doi: 10.3390/pathogens12121380. Pathogens. 2023. PMID: 38133265 Free PMC article. Review.
-
HPV16 Impacts NHERF2 Expression in Oropharyngeal Cancers.Pathogens. 2023 Aug 3;12(8):1013. doi: 10.3390/pathogens12081013. Pathogens. 2023. PMID: 37623973 Free PMC article.
References
-
- An, B., and Q. P. Dou. 1996. Cleavage of retinoblastoma protein during apoptosis: an interleukin 1 beta-converting enzyme-like protease as candidate. Cancer Res. 56:438-442. - PubMed
-
- Banks, L., C. Edmonds, and K. Vousden. 1990. Ability of the HPV16 E7 protein to bind RB and induce DNA synthesis is not sufficient for efficient transforming activity in NIH 3T3 cells. Oncogene 5:1383-1389. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
